Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REMIT Pilot: Intensive Metabolic Intervention in Type 2 Diabetes
NCT01181674Phase 4Completed
- Sponsor
- Population Health Research Institute
- Start
- Jan 2011
- Primary completion
- Feb 2015
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of insulin glargine, liquid metformin (Aspargo Labs), acarbose in type 2 diabetes mellitus (T2DM), sponsored by Population Health Research Institute. Started Jan 2011; status: completed.
02
Drugs
insulin glargineliquid metformin (Aspargo Labs)acarbose
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01181674.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01181674.